Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dexmedetomidine-esketamine Combination on Sleep Disturbances After Major Noncardiac Surgery: a Single-center, Randomised, Double-blind, Placebo-controlled Trial

NCT06859892 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06859892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06859892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dexmedetomidine-esketamine Combination on Sleep Disturbances After Major Noncardiac Surgery: a Single-center, Randomised, Double-blind, Placebo-controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
March 18, 2025
Completion date
December 31, 2026
Enrollment
476 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adults, dexmedetomidine, esketamine, major noncardiac surgery, postoperative sleep disturbances